Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio.
about
Dysfunctional counting of mental time in Parkinson's disease.(123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological DiseasesThe utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson's DiseaseEarly-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?Multipinhole collimator with 20 apertures for a brain SPECT application.Comparison between Different Intensity Normalization Methods in 123I-Ioflupane Imaging for the Automatic Detection of Parkinsonism.Fully Automated Quantification of the Striatal Uptake Ratio of [(99m)Tc]-TRODAT with SPECT Imaging: Evaluation of the Diagnostic Performance in Parkinson's Disease and the Temporal Regression of Striatal Tracer Uptake.Multivariate Analysis of 18F-DMFP PET Data to Assist the Diagnosis of ParkinsonismUtility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's diseaseCADA-computer-aided DaTSCAN analysis.Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's DiseaseReduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy.Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECTImaging analysis of Parkinson's disease patients using SPECT and tractographyThe impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging.[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods.SPECT imaging evaluation in movement disorders: far beyond visual assessment.Improving quantitative dosimetry in (177)Lu-DOTATATE SPECT by energy window-based scatter corrections.Improved Parkinsonism diagnosis using a partial least squares based approach.Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT.Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT.Radius dependence of FP-CIT quantification: a Monte Carlo-based simulation study.Experimental determination of the weighting factor for the energy window subtraction-based downscatter correction for I-123 in brain SPECT studies.Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging.Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use?European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.Comment on Mertens et al.: Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database.Comparison of machine learning and semi-quantification algorithms for (I123)FP-CIT classification: the beginning of the end for semi-quantification?Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration.Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson's disease.The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with Lewy123I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies.REM sleep without atonia in middle-aged and older psychiatric patients and Lewy body disease: a case series.Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [123I]FP-CIT SPECT images.Rapid eye movement sleep without atonia may help diagnose Lewy body disease in middle-aged and older patients with somatic symptom disorder.Inter- and intra-observer reproducibility of quantitative analysis for FP-CIT SPECT in patients with DLB.Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls.
P2860
Q27317224-618E78C6-1026-4909-BF75-CE264A2FB589Q28067098-E5B067BF-E2AE-431D-82D8-CE93652CC915Q33693399-339658C9-968F-4C4D-B773-51A7E12F9931Q33700944-A36387FC-B27B-4C1C-AFC8-72407F05F43BQ33765779-91C30650-880A-48E7-8FC6-B3CAABA44CA1Q34445087-DE5A487E-18C8-4DF9-9F76-985808734D50Q35667024-8563E023-5EF3-4EDF-BCE7-3A439FF39A48Q36022062-D26FD991-2383-43B3-8E7C-9B1CB7E6EEAFQ36351415-1A7930F8-C7AC-47FC-887A-B7C51446668CQ36373719-A42E27C2-B992-4D72-899D-7E446F17A8BEQ36582004-27A39138-D893-45CF-9FE0-2A8C8BFBDA43Q36685622-D33BAC40-FA8A-48B0-9159-8524F6E7E262Q36876994-7936B667-4721-4EFD-9A49-4AE4A3F5D20DQ37371165-B9009614-063E-4030-B146-9AF8130C0F47Q37454387-07AAE777-9E75-46E9-AA00-7E4157C09FA8Q37605294-D5B70B83-AB70-44E4-BCD3-E7F785F0DB61Q37610763-62B282EB-7314-4EE0-9538-AAECD53A65C4Q37815026-19F6CB20-7333-4001-AC24-2D84FBE7D355Q38551420-6B18A356-3E51-4A32-9ADF-A7D7527AC3C1Q38779219-759C1270-7125-42C6-A190-24A1C4F22432Q38851094-B22A81A2-9970-4632-BDE5-C5539B744149Q39051531-31909FF7-69A5-4823-8A0A-8C8DE657FA3BQ39470837-B744279E-65F0-4C02-B014-302A6BBDFF5BQ40151900-8DFFFBA8-BCAC-4464-88ED-921FC031D9D8Q41666335-47DDAADE-463A-4E3A-A58F-9E4B02B9906EQ42094454-84A05168-CD72-42BB-BB26-BBC160B68112Q42776827-10B21815-1254-4F75-89DF-B9D5A3A293EFQ43948177-BD93D4F4-BB1F-4C87-A14A-4F99A78D6E0FQ44778380-F6524BEE-73F4-45A8-B090-FA4C710C21F1Q45146077-139070B9-D0B8-40FC-A55F-D6B5CBD1DF5FQ45943418-BCA68DB1-56F1-4B55-BAF2-AE5A87885AADQ47142839-63889D4E-970A-45C7-A6F0-4D9C5F3F363BQ47590524-F216C6CD-5FA7-4859-B1D7-642F190F4A93Q47769902-4F5BBD12-E1E3-4C43-9C6B-2D0978591D5DQ47830592-C2B54C17-8D66-4D47-B780-90AF745C6EB3Q47864032-6E71DACB-442A-480A-BD71-82C97AA42459Q47897195-34756921-7D45-462D-B649-E8607D372397Q47899952-A6C65553-1F5E-42B6-A168-36BFCC724BD3Q48111729-FB2B1A40-1C28-412D-9F5B-A61834142660Q48693663-96350123-82CF-4E88-B116-1C26254F23ED
P2860
Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@en
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@nl
type
label
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@en
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@nl
prefLabel
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@en
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@nl
P2093
P2860
P1476
Quantification of [123I]FP-CIT ...... of the specific binding ratio.
@en
P2093
John S Fleming
Livia Tossici-Bolt
Paul M Kemp
Rajnikant L Mehta
Sandra M A Hoffmann
P2860
P2888
P304
P356
10.1007/S00259-006-0155-X
P577
2006-07-21T00:00:00Z